Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450

Spreading of the multidrug-resistant (MDR) strains of the one of the most harmful pathogen Mycobacterium tuberculosis (Mtb) generates the need for new effective drugs. SQ109 showed activity against resistant Mtb and already advanced to Phase II/III clinical trials. Fast SQ109 degradation is attribut...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukhdruker, Sergey, Varaksa, Tatsiana, Grabovec, Irina, Marin, Egor, Shabunya, Polina, Kadukova, Maria, Grudinin, Sergei, Kavaleuski, Anton, Gusach, Anastasiia, Gilep, Andrei, Borshchevskiy, Valentin, Strushkevich, Natallia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589583/
https://www.ncbi.nlm.nih.gov/pubmed/33081390
http://dx.doi.org/10.3390/ijms21207683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589583/
https://www.ncbi.nlm.nih.gov/pubmed/33081390
http://dx.doi.org/10.3390/ijms21207683

Ejemplares similares